TRIP Logo

What’s Happening With TripAdvisor’s Stock?

by Trefis Team
TripAdvisor’s stock (NASDAQ: TRIP), currently at around $33 has climbed more than 75% since November as vaccine efficacy data and approvals rolled out. In addition, the Presidential elections and better-than-expected Q3 results added to th...
Read More >   |   Share
AA Logo

Alcoa Stock Drops 18% In A Week – What Should You Know?

by Trefis Team
Alcoa stock (NYSE: AA) dropped 18% in just the last one week. What’s somewhat baffling, at first,  is that this happened after the company beat analysts’ expectations in the recently announced Q4 and FY2020 results. by a huge margin. The company ...
Read More >   |   Share
C Logo

Citigroup Stock Is Trading 25% Below Its Fair Value

by Trefis Team
[Updated 01/22/2021] Citigroup Update Citigroup stock  (NYSE: C) is currently trading close to $62, which is 75% above the March 23 lows of the last year and almost 21% below its pre-Covid peak. Trefis estimates  Citigroup’s valuation to be...
Read More >   |   Share
JNJ Logo

Should You Buy Johnson & Johnson Stock At $160?

by Trefis Team
Despite a 45% rise since the March 23 lows of last year, at the current price of around $161 per share we believe that pharmaceuticals bellwether, Johnson & Johnson (NYSE: JNJ), looks attractive and it can see more upside from the current lev...
Read More >   |   Share

Should You Book Profits In Pacific Biosciences of California After A Massive 13x Rally?

by Trefis Team
After a large 13x rise since the March 23 levels of last year, at the current price of around $36 per share we believe Pacific Biosciences of California stock (NASDAQ: PACB), a biotechnology company that develops gene sequencing systems, has reac...
Read More >   |   Share

Can Editas Medicine Stock Bounce Back After A 13% Drop In 5 Days ?

by Trefis Team
Editas Medicine (NASDAQ: EDIT), a biotechnology company focused on developing treatments using gene editing technology, has plunged by 13% over the last 5 trading days, after the company stated its plans to issue 3.5 million shares at $66 per sha...
Read More >   |   Share

Is Vaxart Stock Worth The Risk?

by Trefis Team
Biotech company Vaxart (NASDAQ:VXRT)   stock is up by over 11x through the last 12 months rising to levels of around $7 per share, driven by the company’s efforts to develop a Covid-19 vaccine. Vaxart, which focuses on oral recombinant vacc...
Read More >   |   Share

Down 25% From December Highs, Is Snowflake Stock A Buy?

by Trefis Team
Snowflake (NYSE: SNOW) stock trades at levels of around $286, down by roughly 26% from its December highs driven in part by a partial lock-up expiration, which allowed employees to sell a portion of their vested options, and some sell-side analys...
Read More >   |   Share
RIO Logo

Rio Tinto Rises 36% In 3 Months; Stay Patient To Earn More

by Trefis Team
Rio Tinto stock (NYSE: RIO) jumped almost 36% in the last three months and currently trades around $80 per share. This rise was driven by the sharp increase of more than 50% in global iron ore prices in three months. Iron ore price per ton incr...
Read More >   |   Share

Nio, Li Auto, and Xpeng: Which Chinese EV Stock Is The Best Value?

by Trefis Team
In late October 2020, we compared the three U.S. listed Chinese electric vehicle (EV) players, Nio (NYSE: NIO), Li Auto (NASDAQ: LI), and Xpeng (NYSE: XPEV). The stocks have had a solid run since then. Over the last three months, Nio stock is up ...
Read More >   |   Share

Is Jabil The Best Stock To Play iPhone 12 Cycle Without Overpaying?

by Trefis Team
Jabil (NYSE: JBL),  a manufacturing services company that counts Apple as its largest customer, has seen its stock price rise by over 80% since late 2018, while surging almost 2.5x from its March 2020 lows. The recent gains have been driven by st...
Read More >   |   Share

Is Cintas Stock Poised To Rise?

by Trefis Team
Cintas (NASDAQ:CTAS) stock, a provider of corporate identity uniforms through rental and sales programs, has declined 6% year-to-date and also declined around 2% over the last 5 trading days. In comparison, the broader S&P 500 returned around...
Read More >   |   Share
MO Logo

Can Altria Stock Surpass Its Pre-Covid Level?

by Trefis Team
We believe Altria stock (NYSE: MO) may be a decent opportunity at the moment. MO trades at $41 currently and is in fact down 18% from $50 at the beginning of 2020. It traded at close to $45 in February 2020, just before the outbreak of the pand...
Read More >   |   Share
LMT Logo

Lockheed Martin Stock Looks Undervalued

by Trefis Team
Recently, concerns regarding full production of F-35s took a toll on the shares of Lockheed Martin (NYSE: LMT) despite multiple contracts awarded by the U.S. military and the recent bid to acquire Aerojet Rocketdyne. Lockheed Martin’s revenues ...
Read More >   |   Share

Can The Gains Continue For Adverum Biosciences After An 18% Move In 5 Days?

by Trefis Team
Adverum Biosciences (NASDAQ: ADVM) stock, a clinical stage gene therapy company focused on serious ocular and rare diseases,  has rallied by a solid 18% over the last 5 trading days, after the company disclosed in regulatory filings that CEO Laur...
Read More >   |   Share